Imaging only (n=2207) | PaLND (n=333) | P value | |
Age (years) | |||
<50 >50 | 1470 (45.8%) 1737 (54.2%) | 209 (62.8%) 124 (37.2%) | <0.001 |
Race | |||
White Other/Unknown | 2438 (76%) 769 (24%) | 251 (75.4%) 82 (24.6%) | 0.79 |
Comorbidities | |||
No Yes | 2706 (84.4%) 501 (15.6%) | 304 (91.3%) 29 (8.7%) | <0.001 |
Insurance | |||
Private Government Uninsured/Unknown | 1211 (37.8%) 1569 (48.9%) 427 (13.3%) | 163 (48.9%) 129 (38.7%) 41 (12.4%) | <0.001 |
Year of diagnosis | |||
2010–2012 2013–2015 | 1360 (42.4%) 1847 (57.6%) | 174 (52.3%) 159 (47.7%) | <0.001 |
Histology | |||
Squamous Adenocarcinoma Adenosquamous | 2706 (84.4%) 431 (13.4%) 70 (2.2%) | 286 (85.9%) 34 (10.2%) 13 (3.9%) | 0.043 |
Stage | |||
IB2-II III-IVA | 1721 (53.7%) 1486 (46.3%) | 179 (53.8%) 154 (46.2%) | 0.98 |
Vaginal brachytherapy | |||
No Yes | 933 (29.1%) 2274 (70.9%) | 77 (23.1%) 256 (76.9%) | 0.022 |
Travel distance (miles)* | |||
<12.5 12.5–49.9 >50 | 1722 (53.8%) 1038 (32.4%) 443 (13.8%) | 172 (51.7%) 112 (33.6%) 49 (14.7%) | 0.76 |
*missing for 4 cases.
PaLND, para-aortic lymphadenectomy.